Can Pentoxifylline improve long-term outcomes in preterm infants with late-onset sepsis or necrotizing enterocolitis – a pragmatic, randomized, controlled trial [ 2016 - 2020 ]

Research Grant

Researchers: Prof Karen Simmer (Principal investigator) ,  A/Pr Tobias Strunk ,  Dr Wendy Hague ,  Prof Dorota Doherty ,  Prof Peter Anderson
View all 8 related researchers

Brief description Very preterm infants are at high risk of death and disability. Brain injury is often the result of inflammation caused by infection or bowel disease. To date, there is no treatment to reduce the harmful effects of inflammation. Pentoxifylline reduces inflammation and is a promising, safe and inexpensive treatment option for preterm infants. This study will determine whether Pentoxifylline in addition to antibiotics improves survival without disability in preterm infants.

Funding Amount $AUD 2,994,020.88

Funding Scheme Project Grants

Notes Standard Project Grant